Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04315883 · ClinicalTrials.gov registry record
Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
A clinical trial, sponsored by Nemours Children's Clinic.
- Terminated
- Registry status
- 3
- Enrollment target
NCT04315883: Clinical Trial study, sponsored by Nemours Children's Clinic.
NCT04315883 is a clinical trial that was terminated before completion, run by Nemours Children's Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04315883 was terminated before completion, sponsored by Nemours Children's Clinic.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This study will be performed to evaluate the Clinical Outcomes and Quality of Life after Transarterial Radioembolization with Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults with Liver Tumors. The treatment and techniques used here are well established in adults. The purpose of this study is to evaluate: 1. the response to treatment and clinical outcomes of treatment with TARE Y-90 as part of standard therapy and 2. to assess the change in the patient's quality of life before, during and after treatment with TARE-Y90
Primary Outcome
Evaluation of change of HRQOL survey responses will be performed: -at baseline (time of treatment) The HRQOL will be done by phone, mail or email. Responses will be captured and entered into a REDCAP database
Interventions
- BEHAVIORAL Quality of Life Assessment
- RADIATION Transarterial Radioembolization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-02-11 |
| Est. Completion | 2024-03-28 |
Why NCT04315883 stopped before completion
NCT04315883 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Quality of Life Assessment is the first listed.
NCT04315883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04315883 about?
NCT04315883 is a clinical study titled "Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors". This study will be performed to evaluate the Clinical Outcomes and Quality of Life after Transarterial Radioembolization with Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults with Liver Tumors. The treatment and techniques used here are well established in adults. The purpose of thi...
What is the current status of trial NCT04315883?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2021-02-11. Estimated completion is 2024-03-28.
What interventions are being tested in trial NCT04315883?
The interventions under investigation include: Quality of Life Assessment (BEHAVIORAL), Transarterial Radioembolization (RADIATION).
Who is sponsoring clinical trial NCT04315883?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI